At the same time, the combination of circRNAs with epidermal growth factor receptor (EGFR) [19] or histone deacetylase (HDAC) inhibitors [20] has shown significant potential in restoring drug sensitivity in resistant glioma cells. The gene discussed is HDAC9; the disease is glioma.